» Articles » PMID: 26334879

Patterns of Diagnostic Imaging and Associated Radiation Exposure Among Long-term Survivors of Young Adult Cancer: a Population-based Cohort Study

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2015 Sep 4
PMID 26334879
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Survivors of young adult malignancies are at risk of accumulated exposures to radiation from repetitive diagnostic imaging. We designed a population-based cohort study to describe patterns of diagnostic imaging and cumulative diagnostic radiation exposure among survivors of young adult cancer during a survivorship time period where surveillance imaging is not typically warranted.

Methods: Young adults aged 20-44 diagnosed with invasive malignancy in Ontario from 1992-1999 who lived at least 5 years from diagnosis were identified using the Ontario Cancer Registry and matched 5 to 1 to randomly selected cancer-free persons. We determined receipt of 5 modalities of diagnostic imaging and associated radiation dose received by survivors and controls from years 5-15 after diagnosis or matched referent date through administrative data. Matched pairs were censored six months prior to evidence of recurrence.

Results: 20,911 survivors and 104,524 controls had a median of 13.5 years observation. Survivors received all modalities of diagnostic imaging at significantly higher rates than controls. Survivors received CT at a 3.49-fold higher rate (95% Confidence Interval [CI]:3.37, 3.62) than controls in years 5 to 15 after diagnosis. Survivors received a mean radiation dose of 26 miliSieverts solely from diagnostic imaging in the same time period, a 4.57-fold higher dose than matched controls (95% CI: 4.39, 4.81).

Conclusions: Long-term survivors of young adult cancer have a markedly higher rate of diagnostic imaging over time than matched controls, imaging associated with substantial radiation exposure, during a time period when surveillance is not routinely recommended.

Citing Articles

Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.

Baltz A, Siegel E, Kamal A, Siegel R, Kozlik M, Crist S JCO Oncol Pract. 2022; 19(2):e274-e285.

PMID: 36375114 PMC: 9970287. DOI: 10.1200/OP.22.00500.


Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

Mullen E, Chi Y, Hibbitts E, Anderson J, Steacy K, Geller J J Clin Oncol. 2018; :JCO1800076.

PMID: 30335557 PMC: 6269130. DOI: 10.1200/JCO.18.00076.


Prevalence and Correlates of Worry About Medical Imaging Radiation Among United States Cancer Survivors.

Hay J, Baser R, Westerman J, Ford J Int J Behav Med. 2018; 25(5):569-578.

PMID: 29872990 PMC: 6281846. DOI: 10.1007/s12529-018-9730-3.


Factors associated with imaging in patients with early breast cancer after initial treatment.

Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N Curr Oncol. 2018; 25(2):126-132.

PMID: 29719428 PMC: 5927783. DOI: 10.3747/co.25.3838.


Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission: A Propensity Score Matched Cohort Study.

Acuna S, Sutradhar R, Kim S, Baxter N Transplantation. 2018; 102(7):1156-1164.

PMID: 29557910 PMC: 7228636. DOI: 10.1097/TP.0000000000002178.


References
1.
Preston D, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M . Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168(1):1-64. DOI: 10.1667/RR0763.1. View

2.
Daugaard G, Gundgaard M, Mortensen M, Agerbaek M, Holm N, Rorth M . Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol. 2014; 32(34):3817-23. DOI: 10.1200/JCO.2013.53.5831. View

3.
Zelenetz A, Abramson J, Advani R, Andreadis C, Byrd J, Czuczman M . NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. J Natl Compr Canc Netw. 2010; 8(3):288-334. DOI: 10.6004/jnccn.2010.0021. View

4.
Maddams J, Parkin D, Darby S . The cancer burden in the United Kingdom in 2007 due to radiotherapy. Int J Cancer. 2011; 129(12):2885-93. DOI: 10.1002/ijc.26240. View

5.
Mettler Jr F, Huda W, Yoshizumi T, Mahesh M . Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008; 248(1):254-63. DOI: 10.1148/radiol.2481071451. View